| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 05/10/2007 | WO2007053353A2 Pyrrolo[2,3-f] and [3,2-f]isoquinolinone derivatives as 5-hydroxytryptamine-6 ligands |
| 05/10/2007 | WO2007053352A2 Pyrroloquinolinone derivatives as 5-hydroxytryptamine-6 ligands |
| 05/10/2007 | WO2007053145A1 Haloperidol analogs |
| 05/10/2007 | WO2007053131A2 Acrylamide derivatives as antibiotic agents |
| 05/10/2007 | WO2007052794A1 o-SUBSTITUTED ANILINE DERIVATIVE AND ANTIOXIDANT DRUG |
| 05/10/2007 | WO2007052283A1 An improved process for preparing tadalafil and its intermediate |
| 05/10/2007 | WO2007052124A1 Tetrahydronaphthyridine derivative |
| 05/10/2007 | WO2007051630A1 Heterocyclic compounds and their use as antifouling agents |
| 05/10/2007 | WO2007051255A1 Process for the preparation of compounds containing an azacyclic ring system |
| 05/10/2007 | WO2007007282A3 Azabicyclo derivatives as muscarinic receptor antagonists |
| 05/10/2007 | WO2007007281A3 Muscarinic receptor antagonists |
| 05/10/2007 | WO2007002701A3 Anti-inflammatory aryl nitrile compounds |
| 05/10/2007 | WO2006134491A3 New crystalline form of moxifloxacin hydrochloride and process for its preparation |
| 05/10/2007 | WO2006131835A3 Heterocyclic triazines as hypoxic selective protein kinase inhibitors |
| 05/10/2007 | WO2006120573A3 Heterocyclic n-oxides as hypoxic selective protein kinase inhibitors |
| 05/10/2007 | WO2006113875A3 2 - pyrrolidone derivatives and their uses for the treatment of inflammatory conditions and pain |
| 05/10/2007 | WO2006110893A3 Preparation of tadalafil intermediates |
| 05/10/2007 | WO2006086633A3 Substituted fused [1,2]imidazo[4,5-c] ring compounds and methods |
| 05/10/2007 | US20070106077 Synthesis of substituted heterocyclic compounds |
| 05/10/2007 | US20070105929 2, 4, 5 - Trisubstituted Imidazoles And Their Use As Anti-Microbial Agents |
| 05/10/2007 | US20070105900 Pharmaceutical compounds |
| 05/10/2007 | US20070105893 e.g. 2-[(4-Ethoxyphenyl)methyl]-1-(3-methylbutyl)-N,N-bis(2,2,2-trifluoroethyl)-1H-benzimidazole-5-carboxamide; agonists at cannabinoid 2 receptor; analgesic agent, anticarcinogenic agent, neurodegenerative diseases; multiple sclerosis, Parkinson's disease, Huntington's chorea or Alzheimer's disease. |
| 05/10/2007 | US20070105890 Novel condensed imidazole derivative |
| 05/10/2007 | US20070105889 Administering (S)-1-(2,3,7,8-tetrahydrofuro[2,3-g]indol-1-yl)-2-propylamine; serotonin receptor antagonists (5HT/5HT2C) for therapy of disorders of the central nervous system; damage to the central nervous system; cardiovascular disorders; gastrointestinal disorders; diabetes insipidus, and sleep apnea |
| 05/10/2007 | US20070105884 Opiate analogs selective for the delta-opioid receptor |
| 05/10/2007 | US20070105883 Novel physiologically active substances pf127oa, b and c substances |
| 05/10/2007 | US20070105865 Substituted bicyclic quinazolin-4-ylamine derivatives |
| 05/10/2007 | US20070105856 6-benzyl-3-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-2,6-dihydropyrazolo[3,4-c]pyridin-7-one; eating and psychological disorders; obesity, alcoholism |
| 05/10/2007 | US20070105840 Pyrrolo-dihydroisoquinoline derivatives as pde10 inhibitors |
| 05/10/2007 | US20070105784 Substituted quinolines for the treatment of cancer |
| 05/10/2007 | US20070105721 Vinylogous 4-Hpyrones and their use in promoting plant growth |
| 05/10/2007 | CA2628014A1 Ortho-substituted aniline derivative and antioxidant drug |
| 05/10/2007 | CA2627779A1 Crystalline salts of 7-[4-(4-naphthalen-1-yl-piperazin-1-yl)-butoxy]-3,4-dihydro-1h-[1,8]naphthyridin-2-one |
| 05/10/2007 | CA2624625A1 Tetrahydronaphthyridine derivative |
| 05/09/2007 | EP1783128A1 Heterocyclic compounds and their use as antifouling agents |
| 05/09/2007 | EP1783118A2 Preparation of risperidone |
| 05/09/2007 | EP1781667A1 Benzothienopyridines for use as inhibitors of eg5 kinesin |
| 05/09/2007 | EP1781658A1 Imidazoý4,5-d¨pyrimidines, their uses and methods of preparation |
| 05/09/2007 | EP1781656A2 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament |
| 05/09/2007 | EP1781655A2 Triazolopyridine compounds useful for the treatment of inflammation |
| 05/09/2007 | EP1781654A1 Pyrrolo-pyridine kinase modulators |
| 05/09/2007 | EP1781653A1 3,4-disubstituted pyrazoles as cyclin dependent kinases (cdk) or aurora kinase or glycogen synthase 3 (gsk-3) inhibitors |
| 05/09/2007 | EP1781652A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with tetrahydropyridine as crf antagonists |
| 05/09/2007 | EP1781623A1 Compounds and compositions useful as cathepsin s inhibitors |
| 05/09/2007 | EP1781621A1 Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors |
| 05/09/2007 | EP1781618A1 Sigma receptor inhibitors |
| 05/09/2007 | EP1781613A1 Piperidine derivatives as histamine h3 receptor ligands |
| 05/09/2007 | EP1781296A2 Quinazoline derivatives and their use in the treatment of thrombocythemia |
| 05/09/2007 | EP1781288A2 Modulators of muscarinic receptors |
| 05/09/2007 | EP1334092B1 Process for preparation of bicyclic and polycyclic molecules |
| 05/09/2007 | CN1960993A 6,6-bicyclic substituted heterobicyclic protein kinase inhibitors |
| 05/09/2007 | CN1960991A Tetrahydro-imidazo [1,5-A] pyridin derivatives as aldosterone synthase inhibitors |
| 05/09/2007 | CN1960990A Cyclohexylalanine derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
| 05/09/2007 | CN1960977A Quinazoline derivative |
| 05/09/2007 | CN1960973A 1-(1h-indol-1-yl)-3-(4-methylpiperazin-1-yl)-1-phenyl propan-2-ol derivatives and related compounds as modulators of the norepinephrine(NE) and the serotonine(5-HT) activity and the monoamine reuptake |
| 05/09/2007 | CN1960728A Conformationally constrained SMAC mimetics and the uses thereof |
| 05/09/2007 | CN1958585A Rutheniumú¿IIú®complexes of second generation DNA molecule optical switch, and preparation method |
| 05/08/2007 | US7214798 E.g., 2-(Methylamino)-2-oxoethyl 3-[1-(1-isoquinolyl)-4-piperidyl]propylcarbamate hydrochloride and 3{2-[1-(2-quinolyl)-4-piperidyl]-ethyl}-1,3-oxazolidine-2,4-dione; analgesics |
| 05/08/2007 | US7214783 Universal bases for nucleic acid analyses, methods for using universal bases, and kits comprising universal bases |
| 05/08/2007 | US7214703 Compounds for modulators of chemokine activity |
| 05/08/2007 | US7214682 Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido{1,2-a}pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo{1,2-a}pyrimidin-5(1h)one derivatives |
| 05/08/2007 | US7214679 treatment of inflammation, proliferative diseases, and certain cardiovascular disorders as well as Alzheimer's disease; |
| 05/08/2007 | US7214675 Administering the compound N-{2-[2-(4-amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)ethoxy]ethyl}morpholine-4-carboxamide inducing cytokine biosynthesis; Viricides; anticancer agents; immunology moderators |
| 05/08/2007 | CA2339528C Hexahydropyrazolo[4,3-c]pyridine metabolites |
| 05/08/2007 | CA2331870C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 05/03/2007 | WO2007051062A2 Substituted dihydropyridines and methods of use |
| 05/03/2007 | WO2007050612A1 2-amino-3,4-dihydro-pyrido[3,4-d]pyrimidine derivatives useful as inhibitors of beta-secretase (bace) |
| 05/03/2007 | WO2007050124A1 Fused piperidine derivatives and their uses as therapeutic agents |
| 05/03/2007 | WO2007049813A1 BENZO[b]THIOPHEN DERIVATIVE AND PROCESS FOR PRODUCTION THEREOF |
| 05/03/2007 | WO2007049812A1 3-HYDROXYMETHYLBENZO[b]THIOPHENE DERIVATIVE AND METHOD FOR PRODUCING SAME |
| 05/03/2007 | WO2007049771A1 Compound containing basic group and use thereof |
| 05/03/2007 | WO2007049675A1 Polycyclic carbamoylpyridone derivative having inhibitory activity on hiv integrase |
| 05/03/2007 | WO2007049532A1 Aminodihydrothiazine derivative |
| 05/03/2007 | WO2007048918A1 Novel esterified amino compounds having a hydrocarbon ring e with six camptothecin analogue ring members, preparation method thereof and pharmaceutical compositions containing same |
| 05/03/2007 | WO2007048917A1 Novel esterified amino compounds having a hydrocarbon ring e with seven camptothecin-derived ring members, preparation method thereof and pharmaceutical compositions containing same |
| 05/03/2007 | WO2007048843A2 Imidazo-pyridine containing beta agonists, method for producing them and their use as drugs |
| 05/03/2007 | WO2007048732A1 Use of 5-aminopyrazoles for controlling phytopathogenic harmful fungi, novel 5-aminopyrazoles, process for their preparation and composition comprising them |
| 05/03/2007 | WO2007048225A1 A 4-oxo-1- (3-substituted phenyl) -1, 4-dihydro-1, 8-naphthyridine-3-carboxamide phosphodiesterase-4-inhibitor and a method of preparing same |
| 05/03/2007 | WO2007032936A3 Azafused cyclin dependent kinase inhibitors |
| 05/03/2007 | WO2007030934A3 Methods of modulating neurotrophin-mediated activity |
| 05/03/2007 | WO2007025880A3 Pyrazolone derivatives as 11-beta hsd1 inhibitors |
| 05/03/2007 | WO2007023110A3 P38 map kinase inhibitors and methods for using the same |
| 05/03/2007 | WO2007018998A3 Tricyclic benzimidazoles and their use as metabotropic glutamate receptor modulators |
| 05/03/2007 | WO2007011626A3 Histone deacetylase inhibitors |
| 05/03/2007 | WO2007002368A3 Non-nucleoside reverse transcriptase inhibitors |
| 05/03/2007 | WO2006050458A3 Tadalafil crystal forms and processes for preparing them |
| 05/03/2007 | US20070100146 Process for the preparation of imidazo[4,5-c]-quinolin-4-amines |
| 05/03/2007 | US20070100142 Stereoselective Synthesis of Certain Trifluoromethyl-Substituted Alcohols |
| 05/03/2007 | US20070099981 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 05/03/2007 | US20070099980 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 05/03/2007 | US20070099951 4-oxo-1-(3-substituted phenyl)-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitor and a method of preparing same |
| 05/03/2007 | US20070099935 Azole-based kinase inhibitors |
| 05/03/2007 | US20070099915 Inhibitors of the hiv integrase enzyme |
| 05/03/2007 | US20070099912 Pyrrolo[2,3-F] and [3,2-F]Isoquinolinone derivatives as 5-hydroxytryptamine-6 ligands |
| 05/03/2007 | US20070099911 Pyrroloquinolinone derivatives as 5-hydroxytryptamine-6 ligands |
| 05/03/2007 | US20070099910 Such as 1-[4-(4-amino-5-oxo-5H-pyrido[2,3-d]pyrimidin-8-yl)phenyl]-3-(2-fluoro-5-trifluoromethyl phenyl)urea; tyrosine kinase inhibitors, Raf kinase inhibitors; for treatment of tumors; pharmacokinetics; radiotherapy |
| 05/03/2007 | US20070099909 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor |
| 05/03/2007 | US20070099904 Pharmaceutical composition for the treatment of cns and other disorders |
| 05/03/2007 | US20070099901 Hydroxylamine and oxime substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines |
| 05/03/2007 | US20070099896 5,7-Dimethyl-2-thiophen-3-yl-imidazo[1,2-a]pyridin-3-yl)-(1,1,3,3-tetramethylbutyl)-amine;vanilloid/cannabinoid receptor antagonists; analgesics, neuropathic pain; headaches; antiepileptic agents; emetic agents; eating disorders; hypotensive agents; antidepressants; glaucoma; incontinence; prion disease |